Oct 2, 2026 09:30AM
Oct 2, 2026 09:30AM
Sep 3, 2026 07:00AM
Sep 3, 2026 07:00AM
Aug 6, 2026 07:00AM
Aug 4, 2026 01:41PM
Jun 11, 2026 07:00AM Climb Bio reports initial phase 1b data for budoprutug in blood disorder
Jun 11, 2026 07:00AM
Jun 5, 2026 07:00AM
Jun 5, 2026 07:00AM
May 26, 2026 07:00AM
May 14, 2026 07:00AM
May 7, 2026 07:00AM
May 5, 2026 07:04AM Climb Bio reports positive subcutaneous budoprutug data in healthy volunteers
May 5, 2026 07:00AM
May 5, 2026 07:00AM
May 5, 2026 03:08AM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 8, 2026 07:00AM
Apr 8, 2026 07:00AM Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
Apr 7, 2026 05:54PM
Apr 7, 2026 09:54AM
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Mar 5, 2026 07:00AM
Jan 8, 2026 07:05AM Climb Bio begins dosing patients in membranous nephropathy trial
Jan 8, 2026 07:00AM
Nov 6, 2025 07:01AM
Oct 21, 2025 07:00AM
Oct 21, 2025 07:00AM
Oct 21, 2025 07:00AM
Oct 17, 2025 07:00AM
Oct 1, 2025 07:00AM Climb Bio names Susan Altschuller as chief financial officer
Oct 1, 2025 07:00AM
Sep 30, 2025 07:16AM
Sep 29, 2025 07:01AM
Sep 29, 2025 07:00AM
Sep 4, 2025 07:00AM
Aug 12, 2025 07:00AM
Jun 18, 2025 07:01AM Climb Bio (CLYM) Appoints Edgar D. Charles as Chief Medical Officer
Jun 18, 2025 07:00AM
May 14, 2025 07:00AM
Apr 1, 2025 07:03AM
Apr 1, 2025 07:00AM
Mar 25, 2025 04:05PM
Feb 24, 2025 07:04AM
Feb 24, 2025 07:00AM Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
Jan 9, 2025 07:00AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All